MBX Biosciences, Inc., a clinical-stage biopharmaceutical company focused on the discovery and development of novel precision peptide therapies for the treatment of endocrine and...
Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, announced an agreement with Bogotá, Colombia-based Gencell Pharma to extend Parse’s...
BlueSphere Bio, a drug development company focused on novel T-cell receptor (TCR) based therapies for oncology and non-oncology indications, announced a collaboration with NMDP...
Arialys Therapeutics, a biotechnology company pioneering new precision medicines for autoimmune neuropsychiatry, announced the appointment of Peter Flynn, Ph.D., as President and Chief Executive...
Axogen, Inc, a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, announces the launch of its newest product, Avive+...
